TransMedics Group, Inc. TMDX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $605.49M+37.1% | $441.54M+82.7% | $241.62M+159% | $93.46M+209% | ||
| $242.69M+35.2% | $179.46M+105% | $87.53M+211% | $28.19M+210% | ||
| $362.81M+38.4% | $262.08M+70.1% | $154.09M+136% | $65.27M+208% | ||
| 59.9%+0.6pp | 59.4%-4.4pp | 63.8%-6.1pp | 69.8%-0.1pp | ||
| $69.06M+23.4% | $55.97M+55.2% | $36.06M+34.5% | $26.81M+20.2% | ||
| $185.17M+9.8% | $168.62M+41.0% | $119.55M+71.0% | $69.9M+82.6% | ||
| $254.22M+13.2% | $224.59M+22.8% | $182.82M+89.0% | $96.71M+59.6% | ||
| $108.58M+190% | $37.5M+220% | -$31.33M+0.3% | -$31.44M+20.3% | ||
| 17.9%+9.4pp | 8.5%+21.5pp | -13%+20.7pp | -33.6%+96.7pp | ||
| $13.78M-4.4% | $14.41M+33.5% | $10.79M+190% | $3.73M-3.8% | ||
| —— | -$1.72M-183% | $2.06M+143% | -$4.81M-1.2% | ||
| $107.52M+201% | $35.78M— | —— | -$36.17M+18.1% | ||
| -$82.77M-26,293% | $316K+119% | -$1.64M-2,589% | $66K+83.3% | ||
| $190.29M+437% | $35.46M— | —— | -$36.23M+18.1% | ||
| 31.4%+23.4pp | 8%— | —— | -38.8%+107pp | ||
| $4.87+377% | $1.02— | —— | -$1.24+23.0% | ||
| $135.77M+137% | $57.25M+347% | -$23.15M+17.2% | -$27.96M+25.7% | ||
| 22.4%+9.5pp | 13%+22.5pp | -9.6%+20.3pp | -29.9%+94.4pp | ||
| $108.58M+190% | $37.5M+220% | -$31.33M+0.3% | -$31.44M+20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is TransMedics Group, Inc.'s revenue?
- TransMedics Group, Inc. (TMDX) generated $635.9M in revenue over the trailing twelve months, up 30.2% year over year.
- Is TransMedics Group, Inc. profitable?
- TransMedics Group, Inc. reported $171.9M in net income over the trailing twelve months, a 27.0% net margin.
- What are TransMedics Group, Inc.'s profit margins?
- Gross margin is 59.1% and operating margin is 14.9%, with a 27.0% net margin.
- What is TransMedics Group, Inc.'s earnings per share?
- TransMedics Group, Inc.'s diluted EPS over the trailing twelve months is $4.37.
- Where does TransMedics Group, Inc.'s income statement data come from?
- Every line is extracted from TransMedics Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
